Top View
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Pulmonary Artery Hypertension (IPAH)
- Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
- (12) United States Patent (10) Patent No.: US 9,040,483 B2 Glidden Et Al
- Pharmaabkommen A1 E
- (CO) at All Times
- Customs Tariff - Schedule Xxi - 1
- Prostaglandin Receptor
- US20080254036A1.Pdf
- Platelets and New Antiplatelet Drugs
- WO 2017/004040 Al 5 January 2017 (05.01.2017) P O P C T
- Pulmonary Hypertension: Newer Insights
- Current and Emerging Drugs in Pulmonary Vascular Pharmacology Dr AS Paul DM Seminar 08 September 06
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Risk Stratification and Medical Therapy of Pulmonary Arterial Hypertension
- New Pharmacologic Therapy for Hypertension in Pregnancy Byrne TJ*
- Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial Hypertension
- Allan CJ, Halushka PV. Characterization of Human Peripheral Blood Monocyte Thromboxane a 2 Receptors
- (12) United States Patent (10) Patent No.: US 8,946,219 B2 Conley Et Al
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Pharmacotherapy in Pulmonary Arterial Hypertension: a Systematic Review and Meta-Analysis Christopher J Ryerson*, Shalini Nayar, John R Swiston, Don D Sin
- Harmonized Tariff Schedule of the United States (2006) (Rev
- (19) United States (12) Patent Application Publication (10) Pub
- (12) United States Patent (10) Patent No.: US 9,381,198 B2 Glidden Et Al
- Evidence Synthesis in Pulmonary Arterial Hypertension: a Systematic
- (12) United States Patent (10) Patent No.: US 8,455,440 B2 Sinha Et Al